Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Burcu Karadal"'
Autor:
Gina Kim, Burcu Karadal-Ferrena, Jiyue Qin, Ved P. Sharma, Isabelle S. Oktay, Yu Lin, Xianjun Ye, Saeed Asiry, Jessica M. Pastoriza, Esther Cheng, Nurfiza Ladak, John S. Condeelis, Esther Adler, Paula S. Ginter, Timothy D’Alfonso, David Entenberg, Xiaonan Xue, Joseph A. Sparano, Maja H. Oktay
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-11 (2023)
Abstract Black, compared to white, women with residual estrogen receptor-positive (ER+) breast cancer after neoadjuvant chemotherapy (NAC) have worse distant recurrence-free survival (DRFS). Such racial disparity may be due to difference in density o
Externí odkaz:
https://doaj.org/article/709b4bab0c9a4e758abfcd34536d7c48
Autor:
Anastasia-Maria Zavitsanou, Ray Pillai, Yuan Hao, Warren L. Wu, Eric Bartnicki, Triantafyllia Karakousi, Sahith Rajalingam, Alberto Herrera, Angeliki Karatza, Ali Rashidfarrokhi, Sabrina Solis, Metamia Ciampricotti, Anna H. Yeaton, Ellie Ivanova, Corrin A. Wohlhieter, Terkild B. Buus, Makiko Hayashi, Burcu Karadal-Ferrena, Harvey I. Pass, John T. Poirier, Charles M. Rudin, Kwok-Kin Wong, Andre L. Moreira, Kamal M. Khanna, Aristotelis Tsirigos, Thales Papagiannakopoulos, Sergei B. Koralov
Publikováno v:
Cell Reports, Vol 42, Iss 11, Pp 113295- (2023)
Summary: Lung cancer treatment has benefited greatly through advancements in immunotherapies. However, immunotherapy often fails in patients with specific mutations like KEAP1, which are frequently found in lung adenocarcinoma. We established an anti
Externí odkaz:
https://doaj.org/article/240bdf74cb4547dea3fb1640afd7bcf5
Autor:
Alexander Ferrena, Jichuan Wang, Ranxin Zhang, Burcu Karadal-Ferrena, Waleed Al-Hardan, Swapnil Singh, Hasibagan Borjihan, Edward Schwartz, Hongling Zhao, Rui Yang, David Geller, Bang Hoang, Deyou Zheng
PurposeOsteosarcoma (OS) is an aggressive bone malignancy with a poor prognosis. One putative proto-oncogene in OS isSKP2, encoding a substrate recognition factor of the SCF E3 ubiquitin ligase. We previously demonstrated thatSKP2knockout in murine O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2597e32a779dc2d0395cdd9778badb0
https://doi.org/10.1101/2023.05.09.540053
https://doi.org/10.1101/2023.05.09.540053
Autor:
Burcu Karadal, Gina Kim, Ved Sharma, Jessica Pastoriza, Isabelle Oktay, Yu Lin, Xianjun Ye, Jiyue Qin, Esther Cheng, Nurfiza Ladak, John Condeelis, Esther Adler, Paula Ginter, Timothy D’Alfonso, Xiaonan Xue, David Enterberg, Joseph Sparano, Maja Oktay
Publikováno v:
Cancer Research. 83:GS1-02
Background: Black, compared to White women with localized breast cancer have higher mortality and worse distant recurrence free survival (DRFS). This has been attributed to social determinants of health and higher prevalence of triple negative breast
Autor:
Burcu Karadal-Ferrena, Camille L. Duran, Madeline Friedman-DeLuca, Nicole Barth, Prachiben Patel, John S. Condeelis, David Entenberg, Maja H. Oktay
Publikováno v:
Cancer Research. 83:1318-1318
Background: The five-year relative survival rate of female breast cancer patients with distant metastases is only 29%, compared to 99% for localized disease. Among all subtypes, triple negative breast cancer (TNBC) has the poorest outcome due to a hi
Autor:
Sergei B. Koralov, Volkan I. Sayin, Sarah E. LeBoeuf, Triantafyllia R. Karakousi, Shawn M. Davidson, Kwok-Kin Wong, S. RaElle Jackson, Thales Papagiannakopoulos, Burcu Karadal, Warren L. Wu
Publikováno v:
Cell Metab
Summary Rewiring of metabolic pathways is a hallmark of tumorigenesis as cancer cells acquire novel nutrient dependencies to support oncogenic growth. A major genetic subtype of lung adenocarcinoma with KEAP1/NRF2 mutations, which activates the endog
Autor:
Kim, Gina, Karadal-Ferrena, Burcu, Qin, Jiyue, Sharma, Ved P., Oktay, Isabelle S., Lin, Yu, Ye, Xianjun, Asiry, Saeed, Pastoriza, Jessica M., Cheng, Esther, Ladak, Nurfiza, Condeelis, John S., Adler, Esther, Ginter, Paula S., D'Alfonso, Timothy, Entenberg, David, Xue, Xiaonan, Sparano, Joseph A., Oktay, Maja H.
Publikováno v:
NPJ Breast Cancer; 6/13/2023, Vol. 9 Issue 1, p1-11, 11p
Publikováno v:
Clinical Trials Week; 4/30/2024, p1118-1118, 1p
Publikováno v:
Women's Health Weekly; 7/4/2023, p983-983, 1p